Skip to main content

Highlights

  1. 1
    Leukemia · 2021
    PMID: 34545183DOIFirst author5 citations

Publications

26 publications

Active

1 grant
  • Co-I
    Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia
    National Heart, Lung, and Blood Institute · 2020–2027
    R61HL151355-01
Completed grants (6)
  • Co-I
    Clinical Assessment of Anti-cocaine Vaccine dAdGNE in Cocaine Addicts
    National Institute on Drug Abuse · 2019–2024
    U01DA048524-01
  • Co-I
    Phase I Study of an AAVrh.10-Mediated Apolipoprotein E2 Gene Delivery to the CNS for the Treatment of Alzheimer's Disease in E4 Homozygotes
    Alzheimer's Drug Discovery Foundation · 2018–2023
    ADDF 171089-01
  • MPI
    Corneal Confocal Microscopy Quantitative Imaging of Corneal Nerves as a Biomarker of Neurologic Disease in Friedreich's Ataxia
    Friedreich's Ataxia Research Alliance · 2019–2021
    FARA 194201-02
  • Co-I
    Gene Therapy for Cardiac Manifestations of Friedreich's Ataxia
    Friedreich's Ataxia Research Alliance · 2019–2021
    FARA 194278-01
  • PI
    Gene Therapy for the Treatment of Hereditary Angioedema
    National Institute of Allergy and Infectious Diseases · 2016–2019
    R03AI122040-02
  • PI
    Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy: A Gene Therapy Approach
    Parker B. Francis Foundation · 2015–2018Fellowship
    PBF 170604-01

News mentions